News

MS Awareness Month

Submitted by krupa.mistry on Thu, 24/03/2022 - 11:01

March is MS awareness month and is a great opportunity to give people confidence to speak up and share stories. The goal of this month for the National MS Society is to “help people better understand life with MS and become inspired to do whatever it takes to change the world for people living with [the condition]”.1 

Medical Affairs Professionals Society conference 2022

Submitted by krupa.mistry on Tue, 15/03/2022 - 16:58

The Corpus is excited to be attending the Medical Affairs Professionals Society conference in New Orleans, Louisiana next week. Over 700 Medical Affairs professionals from around the world will gather at the conference which will feature industry-leading programming, best practice sharing, and plenty of opportunities for networking. This will be our first live event since 2020 and we are looking forward to seeing everyone in person again! 

The changing landscape of epilepsy treatments: what does the future hold?

Submitted by krupa.mistry on Mon, 21/02/2022 - 11:29

Epilepsy affects approximately 50 million people worldwide and The WHO estimates that up to 70%1 of them could live seizure-free if properly diagnosed and treated. Epilepsy is a chronic disease of the central nervous system which affects people of all ages, ethnicities, locations and socio-economic backgrounds. It is characterised by recurrent, unprovoked seizures, resulting from abnormal neural activity in the brain.2  Seizures can range in severity, type and cause, making the diagnosis and selection of the right treatment particularly difficult for physicians. 

Expansion, carbon-neutrality and augmented reality: just a few things we’ve addressed in 2021

Submitted by Jan Ash on Wed, 22/12/2021 - 09:06

This time last year we were reflecting on the light at the end of the tunnel, with a vaccine being rolled out that would help fight COVID-19. The global situation has certainly improved since then but, unfortunately, we aren’t quite out the other side just yet. 2021 repeatedly threw challenges our way and businesses were forced to continue to adapt and evolve in order to survive. As an online education provider we were in a very fortunate position, and we’ve successfully run hundreds of online meetings over the past 12 months.

Demonstrating real change in clinical practice

Submitted by krupa.mistry on Thu, 09/12/2021 - 14:29

Between May 2019 and March 2020, The Corpus ran an educational programme in atherosclerotic cardiovascular disease (ASCVD) in the Japan-Asia Pacific region. As with many of our online meetings, these were designed to be intimate and interactive affairs with a group of approximately 20 healthcare professionals at each one-hour meeting. Addressing an identified unmet need, the focus on the series was managing low-density lipoprotein cholesterol (LDL-C) levels in patients with ASCVD and reached more than 600 healthcare professionals (HCPs) across the region. 

The future of non-small-cell lung cancer diagnosis and treatment

Submitted by krupa.mistry on Tue, 16/11/2021 - 08:51

Lung cancer is the most common cause of cancer-related death worldwide, of which the vast majority is non-small-cell lung cancer (NSCLC)(1). Early-stage NSCLC can be treated with surgery alone, while later stages are likely to also require adjuvant or combination therapies such as radiotherapy, chemotherapy and immunotherapy. If gene mutations are detected among cancer cells, then targeted therapy could also be administered.

Scratching the surface: electrocardiograms and promising cardiac medical devices

Submitted by Jan Ash on Mon, 02/08/2021 - 10:41

Coupled with the technological advances over recent years, significant developments of diagnostic and monitoring platforms have alleviated pressures faced by front line doctors (1). Within the field of cardiology, the ongoing sophistication of medical devices has improved patient quality of life for a range of different cardiovascular-related illnesses such as ischaemic heart disease and hypertensive diseases.